30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Renal Tumors
The two fusion genes with the highest incidence in Xp11.2 translocation renal cell carcinoma are ASPSCR1-TFE3 and PRCC-TFE3;
The TFE3 fusion subtype, more often than not, exhibits nested or solid lamellar structures with no obvious papillary structures, sparse cell cytoplasm, and low nuclear grade accompanied by a small number of gritty bodies.
Tumors of undetermined differentiation and neoplastic lesions
Detect whether the TFE3 gene is fused to the partner gene PRCC.